Mr Richard Stanton
Prosiectau fel Prif Ymchwiliwr
- Analysis of the antiviral efficacy of Nasaleze (01.04.2021 - 30.06.2023)
- Antiviral capacity of surfaces (01.02.2023 - 31.01.2024)
- Bringing together HCMV researchers within the UK (01.11.2016 - 30.04.2017)
- Bringing together human cytomegalovirus researchers within the UK (01.07.2018 - 31.12.2018)
- Developing a novel anti-SARS-CoV-2 Immunotherapy (01.01.2024 - 31.08.2025)
Prosiectau fel Cyd-Ymchwiliwr
- A randomised controlled trial of the effect of mouthwashes against COVID-19 (08.07.2020 - 15.05.2021)
- A systematic investigation into human cytomegalovirus gene function (08.05.2014 - 31.12.2017)
- Characterisation of a novel class of natural killer cell immunoevasin (01.05.2021 - 28.02.2025)
- Exploring the efficacy and mechanisms of action of a novel formulation (19.11.2022 - 18.05.2023)
- Generation and maintenance of protective immunological memory to influenza to inform vaccine design and therapy or critically ill patients (15.08.2018 - 31.12.2018)